Silence Therapeutics Plc ADR SLN

$10.64 -0.07 (-0.65%)

Valuation

Market cap
644,838,000
Revenue TTM
$560,000
Net income TTM
$-88,610,000
PE ratio
0.00
Forward PE
—
Profit margin
-15,823.21%
Debt to equity
0.00

Trading

Volume
973,300
Avg volume
1,264,566
Day's range
$10.38 – $10.78
Shares out
60,209,000
Stochastic %K
12%
Beta
1.45
Analysts
Strong Sell
Price target
$35.80

Price

Company profile

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It a...

Show more

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.

Industry
Biotechnology
Sector
Healthcare
Phone
44 20 3457 6900
Website
https://www.silence-therapeutics.com
Address
12 Hammersmith Grove, London, United Kingdom

Latest news

Stocktwits

Elessar66 Sep 30, 1:23 PM
$SLN glad I got out in time
0 replies
JeremyDanie Sep 28, 12:54 PM
$SLN
0 replies
laaarsas Sep 25, 1:46 PM
$SLN this price action is depressing to watch. Got out in the 12s, but could have gotten out at 15+. Bad call from me. Market is underestimating the value of this one. Probably dead money for some time now however. Ph3 will be good.
0 replies
GenralP Sep 24, 7:40 PM
$SLN on the fence on this right now.
0 replies
Merlintrader Sep 23, 2:08 PM
Silence Therapeutics ($SLN): Divesiran Phase 3 Start Guided to H1 2027 Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/silence-therapeutics-sln-stock-hub/
0 replies
stockwitsuser2449 Sep 18, 1:35 PM
$SLN FYI this is increasingly vulnerable today, with 5K+ bearish puts signaling mounting downside pressure. $11 /12 could break. Bears are watching $11 closely—lose that level and downside momentum could accelerate fast.
1 replies
LIGator Sep 18, 1:27 PM
$SLN heavy premarket volume. Very unusual for this stock. Could be very interesting today and Monday.
0 replies
Elessar66 Sep 10, 1:27 PM
$SLN big candle up pre-market to 14+.. did i miss anything again?
0 replies